Quantitative mapping of functional MAO-A in the brain with radioiodinated clorgyline derivative
- Kyoto Univ. (Japan); and others
The alteration of monoamine oxidase (MAO) activity in the brain may be associated with a number of neurological and psychiatric disorders. C-11 labeled clorgyline and deprenyl have been reported as imaging agents for MAO in the human brain. In order to expand this imaging technique to SPECT, the authors have reported the synthesis and biological evaluation of a number of iodinated clorgyline derivatives. On this basis, 2,4-dichloro-6-iodo-clorgyline analog (SIC) was selected as the most potential agent for mapping MAO-A with SPECT. In this paper, quantitative mapping of functional MAO-A in the brain with this compound was estimated. Pretreatment study with clorgyline showed the selective binding to MAO-A in the brain at 24 hr post injection of I-125-SIC. Good linear correlation between the enzyme activity and the brain up-take of I-125-SIC was observed in the pretreated study with several dose of clorgyline. Furthermore, local MAO-A activity was estimated by the autoradiographic method. High MAO-A activities were observed in midbrain and pons. This result was well agreed with another reported value obtained in vitro assay. In conclusion, this compound is indicated to be variable for quantitative analysis of MAO-A in the brain with SPECT.
- OSTI ID:
- 198104
- Report Number(s):
- CONF-940605-; ISSN 0161-5505; TRN: 95:007029-0256
- Journal Information:
- Journal of Nuclear Medicine, Vol. 35, Issue Suppl.5; Conference: 41. annual meeting of the Society of Nuclear Medicine, Orlando, FL (United States), 5-8 Jun 1994; Other Information: PBD: May 1994
- Country of Publication:
- United States
- Language:
- English
Similar Records
Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain
(/sup 11/C)clorgyline and (/sup 11/C)-L-deprenyl and their use in measuring functional monoamine oxidase activity in the brain using positron emission tomography